Skip to main content

Arnst Thomas W's Form 4 filing

Tenet Healthcare Corp (THC) · filed Mar 7, 2023

Accession no.
0001209191-23-017020
Filed
Mar 7, 2023
Trade date
Mar 6, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $50.3K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Arnst Thomas WCIK 0001852128Officer (EVP, Chief Admin. Officer & GC)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 6, 2023Common StockMOption exerciseAcquired+4,213–F2–4,213Direct
Mar 6, 2023Common StockFTax withholdingDisposed−1,658$60.62F4−$100,507.962,555Direct
Mar 6, 2023Common StockMOption exerciseAcquired+3,869–F2–6,424Direct
Mar 6, 2023Common StockFTax withholdingDisposed−1,523$59.29F4−$90,298.674,901Direct
Mar 6, 2023Common StockMOption exerciseAcquired+5,531–F2–10,432Direct
Mar 6, 2023Common StockFTax withholdingDisposed−2,177$58.53F4−$127,419.818,255Direct
Mar 6, 2023Common StockMOption exerciseAcquired+21,125–F2–29,380Direct
Mar 6, 2023Common StockFTax withholdingDisposed−5,777$58.53F4−$338,127.8123,603Direct
Mar 6, 2023Common StockSSaleDisposed−825$61.00F8−$50,32522,778Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 6, 2023Common StockMOption exerciseDisposed−4,213$0.00$08,427Direct
Mar 6, 2023Common StockMOption exerciseDisposed−3,869$0.00$04,156Direct
Mar 6, 2023Common StockMOption exerciseDisposed−5,531$0.00$00Direct
Mar 6, 2023Common StockMOption exerciseDisposed−21,125$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Restricted stock units convert into common stock on a one-for-one basis.

Referenced by the price of 4 transactions in Table I.

F4

Represents the closing price of the common stock of the Issuer on the vesting date.

Referenced by the price of 4 transactions in Table I.

F8

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.01. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)